RBC Capital Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $105
Encompass Health Is Maintained at Buy by UBS
Encompass Health Price Target Raised to $110.00/Share From $100.00 by UBS
Encompass Health Analyst Ratings
UBS Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $110
Encompass Health Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Encompass Health (EHC) and Ardent Health Partners, Inc. (ARDT)
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $104
Encompass Health Analyst Ratings
Jefferies Reaffirms Their Buy Rating on Encompass Health (EHC)
Analysts' Top Healthcare Picks: Encompass Health (EHC), Castle Biosciences (CSTL)
Buy Rating Affirmed for Encompass Health on Strong Q2 Performance and Raised Guidance
Encompass Health Analyst Ratings
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating
Barclays Maintains Encompass Health(EHC.US) With Buy Rating, Cuts Target Price to $109
Barclays Keeps Their Buy Rating on Encompass Health (EHC)
Barclays Maintains Encompass Health(EHC.US) With Buy Rating, Maintains Target Price $113
Barclays Keeps Their Buy Rating on Encompass Health (EHC)
Encompass Health Analyst Ratings
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $113